The development of matrix tablets for diclofenac sodium based on an empirical in vitro and in vivo correlation

Hsiu O. Ho, Cheng Hsiung Liu, Hua Mei Lin, Ming Thau Sheu

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Different dissolution media were tested using Voltaren SR® as a model dosage form to develop an in vitro/in vivo correlation for diclofenac sodium. An empirical correlation between the cumulated amount of in vitro dissolution (%) and cumulated AUC (%) was constructed by selecting an appropriate time scale. Dissolution in a water medium for 1 h, followed with simulated intestinal fluid seemed to give better correlation with the AUC in vivo. This approach was tested with four matrix tablets based on hydroxypropylmethylcellulose (HPMC) of varying grades of viscosity and at different ratios. The closeness between in vitro dissolution profile and cumulated AUC change was conclusively demonstrated for these four matrix tablets. Based on this result, a product named Clofen SR® was then designed and was tested in vivo to compare its relative bioavailability with that of Voltaren SR®. The results demonstrated a similar extent of absorption in terms of AUC for Clofen SR® as for Voltaren SR®. However, the fluctuation in plasma concentration was smaller for Clofen SR® than for Voltaren SR® at steady state based on the three pharmacokinetic parameters of C((max)(ss)), C((min)(ss)), and Fluctuation((ss)). It is concluded that this empirical correlation may be able to predict the relative extent of absorption, but fails to indicate the possible erratic concentration change of diclofenac sodium in the plasma.

Original languageEnglish
Pages (from-to)149-156
Number of pages8
JournalJournal of Controlled Release
Volume49
Issue number2-3
DOIs
Publication statusPublished - Dec 15 1997

Fingerprint

Diclofenac
Tablets
Baclofen
Area Under Curve
Dosage Forms
Viscosity
Biological Availability
In Vitro Techniques
Pharmacokinetics
Water

Keywords

  • Bioavailability
  • Correlation
  • Diclofenac sodium
  • Dissolution
  • Matrix tablet

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

The development of matrix tablets for diclofenac sodium based on an empirical in vitro and in vivo correlation. / Ho, Hsiu O.; Liu, Cheng Hsiung; Lin, Hua Mei; Sheu, Ming Thau.

In: Journal of Controlled Release, Vol. 49, No. 2-3, 15.12.1997, p. 149-156.

Research output: Contribution to journalArticle

@article{c08a38e7828040cfa82dedf597821b9f,
title = "The development of matrix tablets for diclofenac sodium based on an empirical in vitro and in vivo correlation",
abstract = "Different dissolution media were tested using Voltaren SR{\circledR} as a model dosage form to develop an in vitro/in vivo correlation for diclofenac sodium. An empirical correlation between the cumulated amount of in vitro dissolution ({\%}) and cumulated AUC ({\%}) was constructed by selecting an appropriate time scale. Dissolution in a water medium for 1 h, followed with simulated intestinal fluid seemed to give better correlation with the AUC in vivo. This approach was tested with four matrix tablets based on hydroxypropylmethylcellulose (HPMC) of varying grades of viscosity and at different ratios. The closeness between in vitro dissolution profile and cumulated AUC change was conclusively demonstrated for these four matrix tablets. Based on this result, a product named Clofen SR{\circledR} was then designed and was tested in vivo to compare its relative bioavailability with that of Voltaren SR{\circledR}. The results demonstrated a similar extent of absorption in terms of AUC for Clofen SR{\circledR} as for Voltaren SR{\circledR}. However, the fluctuation in plasma concentration was smaller for Clofen SR{\circledR} than for Voltaren SR{\circledR} at steady state based on the three pharmacokinetic parameters of C((max)(ss)), C((min)(ss)), and Fluctuation((ss)). It is concluded that this empirical correlation may be able to predict the relative extent of absorption, but fails to indicate the possible erratic concentration change of diclofenac sodium in the plasma.",
keywords = "Bioavailability, Correlation, Diclofenac sodium, Dissolution, Matrix tablet",
author = "Ho, {Hsiu O.} and Liu, {Cheng Hsiung} and Lin, {Hua Mei} and Sheu, {Ming Thau}",
year = "1997",
month = "12",
day = "15",
doi = "10.1016/S0168-3659(97)00067-9",
language = "English",
volume = "49",
pages = "149--156",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - The development of matrix tablets for diclofenac sodium based on an empirical in vitro and in vivo correlation

AU - Ho, Hsiu O.

AU - Liu, Cheng Hsiung

AU - Lin, Hua Mei

AU - Sheu, Ming Thau

PY - 1997/12/15

Y1 - 1997/12/15

N2 - Different dissolution media were tested using Voltaren SR® as a model dosage form to develop an in vitro/in vivo correlation for diclofenac sodium. An empirical correlation between the cumulated amount of in vitro dissolution (%) and cumulated AUC (%) was constructed by selecting an appropriate time scale. Dissolution in a water medium for 1 h, followed with simulated intestinal fluid seemed to give better correlation with the AUC in vivo. This approach was tested with four matrix tablets based on hydroxypropylmethylcellulose (HPMC) of varying grades of viscosity and at different ratios. The closeness between in vitro dissolution profile and cumulated AUC change was conclusively demonstrated for these four matrix tablets. Based on this result, a product named Clofen SR® was then designed and was tested in vivo to compare its relative bioavailability with that of Voltaren SR®. The results demonstrated a similar extent of absorption in terms of AUC for Clofen SR® as for Voltaren SR®. However, the fluctuation in plasma concentration was smaller for Clofen SR® than for Voltaren SR® at steady state based on the three pharmacokinetic parameters of C((max)(ss)), C((min)(ss)), and Fluctuation((ss)). It is concluded that this empirical correlation may be able to predict the relative extent of absorption, but fails to indicate the possible erratic concentration change of diclofenac sodium in the plasma.

AB - Different dissolution media were tested using Voltaren SR® as a model dosage form to develop an in vitro/in vivo correlation for diclofenac sodium. An empirical correlation between the cumulated amount of in vitro dissolution (%) and cumulated AUC (%) was constructed by selecting an appropriate time scale. Dissolution in a water medium for 1 h, followed with simulated intestinal fluid seemed to give better correlation with the AUC in vivo. This approach was tested with four matrix tablets based on hydroxypropylmethylcellulose (HPMC) of varying grades of viscosity and at different ratios. The closeness between in vitro dissolution profile and cumulated AUC change was conclusively demonstrated for these four matrix tablets. Based on this result, a product named Clofen SR® was then designed and was tested in vivo to compare its relative bioavailability with that of Voltaren SR®. The results demonstrated a similar extent of absorption in terms of AUC for Clofen SR® as for Voltaren SR®. However, the fluctuation in plasma concentration was smaller for Clofen SR® than for Voltaren SR® at steady state based on the three pharmacokinetic parameters of C((max)(ss)), C((min)(ss)), and Fluctuation((ss)). It is concluded that this empirical correlation may be able to predict the relative extent of absorption, but fails to indicate the possible erratic concentration change of diclofenac sodium in the plasma.

KW - Bioavailability

KW - Correlation

KW - Diclofenac sodium

KW - Dissolution

KW - Matrix tablet

UR - http://www.scopus.com/inward/record.url?scp=0031460612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031460612&partnerID=8YFLogxK

U2 - 10.1016/S0168-3659(97)00067-9

DO - 10.1016/S0168-3659(97)00067-9

M3 - Article

AN - SCOPUS:0031460612

VL - 49

SP - 149

EP - 156

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 2-3

ER -